Literature DB >> 5011493

[Substitution treatment of factor XIII deficiency with a new factor XIII concentrate].

H Trobisch, R Egbring.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5011493     DOI： 10.1055/s-0028-1107385

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  7 in total

Review 1.  The human fibrin-stabilizing factors.

Authors:  H Bohn
Journal:  Mol Cell Biochem       Date:  1978-06-28       Impact factor: 3.396

2.  [Molecular structure of fibrin stabilizing factors in man. II. Comparative immunologic studies on factor XIII deficient plasma and normal plasma].

Authors:  H Bohn; W Becker; H Trobisch
Journal:  Blut       Date:  1973-05

3.  [Simplified radiologic factor XIII determination and its clinical use in congenital factor XIII deficiency (I)].

Authors:  R Egbring; W Schmidt; K Havemann
Journal:  Blut       Date:  1973-07

Review 4.  [Blood coagulation factor XIII and fibrin stabilization (author's transl)].

Authors:  H Rasche
Journal:  Klin Wochenschr       Date:  1975-12-15

5.  [Longtime therapy of congenital factor XIII deficiency using factor XIII concentrate].

Authors:  R Egbring; K Andrassy; K Havemann; G Fuchs; B Ruf; K Schander; H Trobisch
Journal:  Blut       Date:  1976-12

6.  Factor XIII levels in relation to gynaecological operations.

Authors:  E Kidess; H Miller; A Preisner; R Briel
Journal:  Arch Gynecol       Date:  1979-08

7.  [Severe factor XIII-deficiency. Studies on subunits and turnover of the fibrin stabilizing factor (author's transl)].

Authors:  R Zimmermann; W Ehlers; F Manz; W Meinrenken; R Egbring; H Gemmeke
Journal:  Blut       Date:  1977-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.